[1]
Erin, “Clinicopathologic Factors Associated with Readmissions and ED Visits after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC)”, kjm, vol. 17, no. S2, p. 65, Aug. 2024, doi: 10.17161/kjm.vol17.22700.